UCB (PK) Stock Quote UCBJY - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

98.44

Bid

96.94

Ask

100.03

Volume

11,224

97.76 Day's Range 99.04

43.682 52 Week Range 100.43

Market Cap

37.327B

Previous Close

97.68

Open

98.136

Last Trade

98.24

Last Trade Time

Financial Volume

$ 1,102,509

VWAP

98.2278

Average Volume (3m)

20,293

Shares Outstanding

379,189,796

Dividend Yield

0.94%

PE Ratio

210.98

Earnings Per Share (EPS)

0.9

Revenue

4.87B

Net Profit

343M

UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

Pharmaceutical Preparations

Industry

Chemicals & Allied Products

Website

www.ucb.com

Headquarters

Brussels, Brussels-capital Region, Bel

Founded

1928

UCB (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker UCBJY. The last closing price for UCB (PK) was $97.68. Over the last year, UCB (PK) shares have traded in a share price range of $ 43.682 to $ 100.43.

UCB (PK) currently has 379,189,796 shares outstanding. The market capitalization of UCB (PK) is $37.04 billion. UCB (PK) has a price to earnings ratio (PE ratio) of 210.98.

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services Judges highlight value-added partnership and finance transformation as leading examples of innovation in...

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S.

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S. Results of retrospective analysis show use of newer anti-epilepsy drugs, access to...

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015 PR Newswire ATLANTA, May 16, 2015 ATLANTA, May 16, 2015 /PRNewswire/ -- UCB, a global biopharmaceutical company...

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam - Major milestone for brivaracetam is latest step towards UCB goal of extending treatment...

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annua...

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annual Meeting PR Newswire ATLANTA, Dec. 8, 2014 ATLANTA, Dec. 8, 2014...

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of...

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of partial-onset seizures in epilepsy -- Primary efficacy and safety...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.17	-1.17458086537	99.61	100.43	97.64	5999	98.43160623	DR
4	0.77	0.788368997645	97.67	100.43	94.206	6965	97.1025	DR
12	4.36	4.6343537415	94.08	100.43	86.71	20293	95.26334078	DR
26	22.56	29.7311544544	75.88	100.43	74.55	16201	90.43200455	DR
52	54.758	125.355981869	43.682	100.43	43.682	17499	75.70496611	DR
156	42.07	74.6318963988	56.37	100.43	32.82	20907	51.25709616	DR
260	59.2525	151.202551834	39.1875	100.43	32.45	20026	52.52629145	DR

UCBJY - Frequently Asked Questions (FAQ)

What is the current UCB (PK) share price?

The current share price of UCB (PK) is $ 98.44

How many UCB (PK) shares are in issue?

UCB (PK) has 379,189,796 shares in issue

What is the market cap of UCB (PK)?

The market capitalisation of UCB (PK) is USD 37.04B

What is the 1 year trading range for UCB (PK) share price?

UCB (PK) has traded in the range of $ 43.682 to $ 100.43 during the past year

What is the PE ratio of UCB (PK)?

The price to earnings ratio of UCB (PK) is 210.98

What is the cash to sales ratio of UCB (PK)?

The cash to sales ratio of UCB (PK) is 14.87

What is the reporting currency for UCB (PK)?

UCB (PK) reports financial results in EUR

What is the latest annual turnover for UCB (PK)?

The latest annual turnover of UCB (PK) is EUR 4.87B

What is the latest annual profit for UCB (PK)?

The latest annual profit of UCB (PK) is EUR 343M

What is the registered address of UCB (PK)?

The registered address for UCB (PK) is 60, ALLEE DE LA RECHERCHE, BRUSSELS, BRUSSELS-CAPITAL REGION, B-1070

What is the UCB (PK) website address?

The website address for UCB (PK) is www.ucb.com

Which industry sector does UCB (PK) operate in?

UCB (PK) operates in the CHEMICALS & ALLIED PRODUCTS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EGIOQEdgio Inc (CE)	$ 0.01 (999,900.00%)	584
AAGRAfrican Agriculture Holdings Inc (CE)	$ 0.008 (799,900.00%)	477
THCBFTHC Biomed International Limited (CE)	$ 0.001 (99,900.00%)	100
AEORFAEON REIT Investment Corporation (PK)	$ 796.08 (26,436.00%)	1
EFTReFFECTOR Therapeutics Inc (CE)	$ 0.0002 (19,900.00%)	225
UFABQUnique Fabricating Inc (CE)	$ 0.000001 (-99.98%)	102.53k
VICFFVice Health and Wellness Inc (CE)	$ 0.000001 (-99.97%)	996
SAFSSafer Shot Inc (CE)	$ 0.000001 (-99.93%)	2.54M
ERFBERF Wireless Inc (CE)	$ 0.0001 (-99.89%)	99.77k
ARVLFArrival (CE)	$ 0.0002 (-99.60%)	42.86k
AITXArtificial Intelligence Technology Solutions Inc (PK)	$ 0.0038 (52.00%)	608.97M
HMBLHUMBL Inc (PK)	$ 0.0009 (0.00%)	546.25M
PHILPHI Group Inc (PK)	$ 0.0003 (0.00%)	501.07M
CBIACanopus Biopharma Inc (PK)	$ 0.0002 (100.00%)	281.95M
RDARRaadr Inc (PK)	$ 0.00125 (-10.71%)	169.44M